当前位置: 首页 > 期刊 > 《医药产业资讯》 > 2018年第2期
编号:13247864
碱性鞘磷脂酶与脂类代谢相关疾病的研究进展(4)
http://www.100md.com 2018年1月15日 《中国医药导报》 2018年第2期
     [18] Duan RD,Hindorf U,Cheng Y,et al. Changes of activity and isoforms of alkaline sphingomyelinase(nucleotide pyrophosphatase phosphodiesterase 7)in bile from patients undergoing endoscopic retrograde cholangiopancreatography [J]. BMC Gastroenterol,2014,14:138.

    [19] Khan SA,Thomas HC,Davidson BR. et al. Cholangiocarcinoma [J]. Lancet,2005,366(9493):1303-1314.

    [20] Reddy SB,Patel T. Current approaches to the diagnosis and treatment of cholangiocarcinoma [J]. Curr Gastroenterol Rep,2006,8(1):30-37.

    [21] Liu JJ,Nilsson A,Duan RD. In vitro effects of fat,FA,and cholesterol on sphingomyelin hydrolysis induced by rat intestinal alkaline sphingomyelinase [J]. Lipids,2002, 37(5):469-474.

    [22] Zhang Y,Cheng Y,Hansen GH,et al. Crucial role of alkaline sphingomyelinase in sphingomyelin digestion:a study on enzyme knockout mice [J]. J Lipid Res,2010, 52(4):771-781.

    [23] Maceyka M,Spiegel S. Sphingolipid metabolites in inflammatory disease [J]. Nature,2014,510(7503):58-67.

    [24] Foersch S,Waldner MJ,Neurath MF. Colitis and colorectal cancer [J]. Dig Dis,2012,30(5):469-476.

    [25] Chen Y,Zhang P,Xu SC,et al. Enhanced colonic tumorigenesis in alkaline sphingomyelinase(NPP7)knockout mice [J]. Mol Cancer Ther,2014,14(1):259-267.

    (收稿日期:2017-10-03 本文編辑:张瑜杰), 百拇医药(李欣 张萍 张涛)
上一页1 2 3 4